Skip to main content
. 2014 Jun 15;5(3):342–356. doi: 10.4239/wjd.v5.i3.342

Table 1.

Effects of intensive glucose control on the onset and progression of diabetic kidney disease

Study HbA1c
Outcome of albuminuria or renal events
Intensive treatment Conventional treatment
ACCORD[45] 6.4% vs 7.6% 21% ↓ in onset of microalbuminuria
32% ↓ in progression to macroalbuminuria
ADVANCE[46] 6.5% vs 7.3% 9% ↓ in onset of microalbuminuria
30% ↓ in progression to macroalbuminuria
21% ↓ in renal events
New onset macroalbuminuria
Doubling of serum Cr
Kidney replacement therapy
Death due to kidney disease
VADT[47] 6.9% vs 8.4% 32% ↓ in progression from normal to microalbuminuria or macroalbuminuria
37% ↓ in progression from normal to microalbuminuria to macroalbuminuria
34% ↓ in any increase in albuminuria

ACCORD: Action to Control Cardiovascular Risk in Diabetes; ADVANCE: Action in Diabetes and Vascular disease: Preterax and Diamicron MR Controlled Evaluation; VADT: Veterans Affairs Diabetes Trial.